The microRNA-371-373 (miR-371-373) cluster is specifically expressed in human embryonic stem cells (ESCs) and is thought to be involved in stem cell maintenance. Recently, microRNAs (miRNAs) of this cluster were shown to be frequently upregulated in several human tumors. However, the regulatory mechanism for the involvement of the miR-371-373 cluster in human ESCs or cancer cells remains unclear. In this study, we explored the relationship between this miRNA cluster and the Wnt/b-catenin-signaling pathway, which has been shown to be involved in both stem cell maintenance and tumorigenesis. We show that miR-371-373 expression is induced by lithium chloride and is positively correlated with Wnt/b-catenin-signaling activity in several human cancer cell lines. Mechanistically, three TCF/LEF1-binding elements (TBEs) were identified in the promoter region and shown to be required for Wnt-dependent activation of miR-371-373. Interestingly, we also found that miR-372&373, in turn, activate Wnt/b-catenin signaling. In addition, four protein genes related to the Wnt/b-catenin-signaling pathway were identified as direct targets of miR-372&373, including Dickkopf-1 (DKK1), a well-known inhibitor of Wnt/b-catenin signaling. Using a lentiviral system, we showed that overexpression of miR-372 or miR-373 promotes cell growth and the invasive activity of tumor cells as knockdown of DKK1. Taken together, our study demonstrates a novel b-catenin/ LEF1-miR-372&373-DKK1 regulatory feedback loop, which may have a critical role in regulating the activity of Wnt/b-catenin signaling in human cancer cells.
Introduction
MicroRNAs (miRNAs) are an abundant class of singlestranded, non-coding small RNAs consisting of [21] [22] [23] [24] [25] nucleotides that have emerged as key post-transcriptional regulators of gene expression. Generally, mature miRNAs are integrated into an RNA-inducing silencing complex and associate with the 3 0 untranslated regions (3 0 -UTRs) of specific target mRNAs to suppress protein expression (Bartel, 2004; Eulalio et al., 2008) . After identification of thousands of miRNAs, the challenge has become the exploration of their specific biological functions. Recent miRNA functional studies have mainly focused on their involvement in physiological or pathological processes in the context of generegulatory networks (Inui et al., 2010) .
The microRNA-371-373 (miR-371-373) cluster, a human homolog of the mouse miR-290-295 cluster (Houbaviy et al., 2005) , was originally found to be specifically expressed in human embryonic stem cells (ESCs) (Suh et al., 2004) and is thought to be involved in stem cell pluripotency (Wang et al., 2008; Judson et al., 2009 ). In addition, recent studies have shown that the miR-371-373 cluster of miRNAs was frequently deregulated in human tumors such as testicular germ cell tumors (Voorhoeve et al., 2006; Palmer et al., 2010) , hepatoblastoma (Cairo et al., 2010) and colorectal cancer (CRC) (Bandres et al., 2006; Ng et al., 2009) . Furthermore, the oncogenic role of this miRNA cluster has been defined by genetic screens for oncomirs (Voorhoeve et al., 2006; Huang et al., 2008) . In testicular germ cell tumor cells, miR-372&373 have been shown to collaborate with oncogenic Ras and neutralize p53-mediated cyclin-dependent kinase (CDK) inhibition, possibly by directly targeting LATS2 (Voorhoeve et al., 2006) . In addition, miR-373 has also been reported to promote tumor invasion and metastasis by suppression of CD44 (Huang et al., 2008) . However, the regulatory mechanism that controls specific expression of the miR-371-373 cluster in ESCs remains unclear, and the causes that lead to its deregulation in human cancers are largely unknown.
Specifically expressed miRNAs are usually controlled by pivotal signaling pathways in a given cell type (Xu et al., 2010) . Based on the expression characteristics of the miR-371-373 cluster, we surmised that it might be controlled by signaling pathways that are critical in both ESCs and tumor cells. The Wnt/b-catenin pathway has been implicated in the control of various types of stem cells and shown to have a critical role in maintaining stem cell pluripotency (Dravid et al., 2005; Reya and Clevers, 2005) . In addition, activation of Wnt/b-catenin signaling frequently occurs in various tumors (Giles et al., 2003) . The coincident activity of Wnt/b-catenin signaling and expression of the miR-371-373 cluster in ESCs and cancer cells led us to speculate that the Wnt/ b-catenin pathway is likely involved in the regulation of this cluster.
In the present work, we investigated the interrelation between the miR-371-373 cluster and the Wnt/ b-catenin-signaling pathway. We show that the Wnt/ b-catenin pathway transactivates the expression of the miR-371-373 cluster by direct binding of b-catenin/LEF1 to the proximal promoter. Significantly, we also provide evidence that miR-372&373, in turn, activate Wnt/bcatenin signaling. To clarify the mechanism, several genes implicated in the Wnt-signaling pathway, including Dickkopf-1 (DKK1), TGFBR2, BTG1 and LEFTY1, were identified as direct targets of miR-372&373. Lentiviral overexpression of miR-372 or miR-373, or knockdown of DKK1, promoted tumor cell growth and invasion. Together, these findings elucidate a novel regulatory mechanism in which b-catenin/LEF1, miR-372&373 and DKK1 form a regulatory feedback loop to modulate Wnt/b-catenin signaling.
Results
Expression of the miR-371-373 cluster is positively correlated with Wnt/b-catenin activity in a group of cell lines Previous reports have shown that the miR-371-373 cluster of miRNAs was overexpressed in colon cancers (Bandres et al., 2006; Ng et al., 2009) in which activation of the Wnt/b-catenin pathway has been well-characterized (Giles et al., 2003) . To explore the possible involvement of Wnt/b-catenin signaling in the regulation of the miR-371-373 cluster, we first investigated whether expression of the miR-371-373 cluster was correlated with activity of Wnt/b-catenin signaling in CRC cell lines.
Lithium chloride (LiCl), which has previously been shown to inhibit glycogen synthase kinase-3 (GSK-3) and suppress b-catenin ubiquitination (Klein and Melton, 1996) , was used to stimulate Wnt/b-catenin signaling. The RKO CRC cell line, with intact Wnt/bcatenin signaling and low Wnt/b-catenin activity, was treated with either 30 mM LiCl or NaCl (vehicle control) for different periods of time. Western blotting (WB) showed that b-catenin was stabilized by LiCl and reached peak expression at 6 h ( Figure 1a ), indicating that Wnt/b-catenin signaling was significantly activated. This result was further validated by Topflash/Fopflash assay. A luciferase reporter plasmid harboring three optimal TCF/LEF1-binding sites (Topflash) or three mutated TCF/LEF1-binding sites (Fopflash) was transfected into RKO cells, and results showed that Topflash/ Fopflash activity was induced by over 2.5-fold by LiCl treatment (Figure 1b) . We then detected the expression of the miR-371-373 cluster by quantitative reverse transcription (RT)-PCR. The miR-371-373 cluster is composed of miR-371-3p, miR-371-5p, miR-372 and miR-373. As shown in Figure 1c , the miR-371-373 cluster of miRNAs was upregulated by LiCl treatment to different extents. These data show that expression of the miR-371-373 cluster was upregulated when Wnt/bcatenin signaling was activated.
We next analyzed the expression of the miR-371-373 cluster and the activities of Wnt/b-catenin signaling in different CRC cell lines, in addition to MCF7 and human embryonic kidney (HEK) 293T cells. Wnt/bcatenin activity in different cell lines was analyzed by Topflash/Fopflash assays as above, and results showed that Topflash/Topflash activities were high in Caco-2 SW480 and HCT15 cells; moderate in HCT116 cells; and low in RKO, HEK293T and MCF7 cells (Figure 1d ). We then examined the expression of the miR-371-373 cluster in these cell lines by quantitative RT-PCR. As shown in Figure 1e , the miRNAs of the miR-371-373 cluster showed similar expression patterns and were significantly coincident with Topflash/ Fopflash activity in these cell lines. These data indicate that expression of the miR-371-373 cluster is positively correlated with Wnt/b-catenin activity in CRC cell lines. Taken together, these results suggest that the miR-371-373 cluster might be co-regulated by Wnt/b-catenin signaling.
b-Catenin/LEF1 transactivates the expression of the miR-371-373 cluster by directly binding to the promoter region To investigate whether Wnt/b-catenin signaling is involved in the transcriptional regulation of the miR-371-373 cluster, we analyzed the promoter region of the miR-371-373 cluster. To date, studies of the genome and the transcription of the miR-371-373 cluster have been limited and were derived mainly from its mouse homolog, the miR-290-295 cluster (Houbaviy et al., 2005) . Because of poor conservation of genome organization between the two homologs (Houbaviy et al., 2005) , we first determined the full-length primary transcript of the miR-371-373 cluster by 5 0 RACE (5 0 Rapid Amplification of cDNA Ends) and 3 0 RACE assays. A single transcriptional start site (TSS) and three transcriptional termination sites were identified (Supplementary Figure 1 ). The TSS is located 30 bp downstream from the predicted TATA-box (TATATAA), which differs from the predicted TSS of the mouse miR-290-295 cluster (Houbaviy et al., 2005) . The three transcriptional termination sites are distributed in an 800-bp region downstream from the pre-miR-373 sequence ( Figure 2a and Supplementary Figure 1) .
The TCF/LEF1 family of HMG-box transcription factors are key mediators of canonical Wnt signaling. Upon Wnt/b-catenin signaling activation, b-catenin is translocated into the nucleus and binds to TCF/LEF1, which then activates the expression of the target gene (Clevers, 2006) . To investigate whether activated expression of the miR-371-373 cluster by Wnt/b-catenin signaling is mediated directly by TCF/LEF1, we searched the predicted promoter region of the miR-371-373 cluster surrounding the TSS for the consensus binding elements of TCF/LEF1 (TBEs) using the TRANSFAC database and the TESS program (Transcription Element Search Software; http:// www.cbil.upenn.edu/tess). Five TBEs were found in a region approximately 1.8 kb upstream from the TSS (Figure 2a) . A fragment harboring the putative promoter and five TBEs (À1724 to þ 55, F1/F0) was amplified and cloned into the pGL3-Basic vector. Five other fragments representing different deletions in the 5 0 region and harboring different numbers of TBEs were also constructed ( Figure 2a ). The reporter gene activities driven by these fragments were determined by luciferase assays. Compared with the pGL3-Basic control, the luciferase activity driven by the F1/F0 fragment was over 120-fold higher in HCT15 cells ( Supplementary  Figure 2) , suggesting the fragment contained a functional promoter.
We next detected the response of truncations containing different numbers of TBEs to LiCl treatment in HEK293T cells. As shown in Figure 2b , the luciferase activity conferred by the F1/F0 fragment harboring five TBEs was upregulated by over 1.6-fold by LiCl, suggesting that the isolated fragment was responsive to Wnt/b-catenin signaling. By contrast, responsiveness was decreased using fragments F2/F0 and F3/F0, and with fragment F4/F0, responsiveness was even further decreased. However, when using fragment F5/F0 in which only TBE5 was contained, or F6/F0 in which all of the TBEs were truncated, response was almost eliminated (Figure 2b ).
We next analyzed the effect of b-catenin overexpression on reporter gene activity, and results were highly coincident with those presented above ( Figure 2c ). Furthermore, mutation of TBE1, TBE3 or TBE4 attenuated the b-catenin-mediated activation of the reporter gene, and simultaneous mutation of TBE1, TBE3 and TBE4 almost completely eliminated responsiveness to b-catenin ( Figure 2d ). Conversely, mutation of TBE2 or TBE5 had almost no effect (data not shown). These results indicate that the miR-371-373 promoter is responsive to Wnt/b-catenin signaling. Additionally, TBE1, TBE3 and TBE4 were required for the Wnt-dependent induction of miRNAs.
Of the TCF/LEF1 family of HMG-box transcriptional factors, LEF1, TCF4 and TCF1 were known to be most relevant to CRCs (Wong and Pignatelli, 2002) (Supplementary Figure 3) . To validate direct binding of LEF1, TCF4 or TCF1 to the TBEs in vitro, electrophoretic mobility-shift assays (EMSA) were performed. A shifted band was detected using a labeled wild-type (WT) oligonucleotide harboring TBE1, TBE3 or TBE4 (Figure 2e ). The intensity of the shifted bands was The data were log 10 -transformed after being normalized to the U6 internal control and the HEK293T cell line control. All of the experiments were performed at least twice in triplicate (nX6). reduced or abolished by 10 or 50-fold molar excess of the unlabeled WT oligonucleotides, respectively, but not using mutant-type (MT) oligonucleotides (Figure 2e ). To determine the TCF/LEF1 factors that may bind to these TBEs, we assayed for supershifts with the addition of antibody against LEF1, TCF4 or TCF1 to the reactions. As shown in Figure 2e , the shifted band was further retarded in its migration by the LEF1 antibody but not normal IgG or others (data not shown).
We next performed chromatin immunoprecipitation assays to confirm in vivo binding of b-catenin/LEF1 to the sites in HCT15 cells. As demonstrated in Figure 2f , LEF1 and b-catenin can indeed bind to the TBE1, TBE3 and TBE4 sites, as well as the TBE in the c-Myc gene promoter (positive control), but not the coding region of c-Jun.
Finally, we tested the effect of LEF1 and b-catenin on the expression of the miR-371-373 cluster. As shown in Figure 2g , the miR-371-373 cluster of miRNAs was markedly activated by LEF1 in HCT116 cells, which express high b-catenin but low LEF1 (Supplementary Figure 3) . Moreover, knockdown of b-catenin by a short interfering RNA downregulated the miR-371-373 cluster expression obviously in HCT15 cells (Figure 2h ). Together, these results suggest that b-catenin/LEF1 mediates the Wnt-induced activation of miR-371-373 by specifically binding to TBE1, TBE3 and TBE4 in the promoter.
miR-372&373 activate the Wnt/b-catenin-signaling pathway The correlation between expression of the miR-371-373 cluster and activity of Wnt/b-catenin signaling in CRC cells also suggested the possibility that the miR-371-373 cluster of miRNAs might also regulate Wnt/b-catenin signaling; thus, we tested whether changes in the expression of the miR-371-373 cluster miRNAs could impact TCF/LEF1 transcriptional activity. MCF7 cells with low Wnt/b-catenin activity were used in this experiment. miRNA mimics for miR-371-3p, miR-371-5p, miR-372 and miR-373 were transfected into MCF7 cells, respectively, and Topflash/Fopflash assays were performed. Surprisingly, miR-372 and miR-373 notably activated Topflash/Fopflash reporter activity by at least 1.4-fold compared with the mimic control, but not miR-371-3p or miR-371-5p (Figure 3a) . Thus miR-372 and miR-373 were selected for further investigation.
Next, we examined the effect of miR-372 and miR-373 on the expression of the activated, unphosphorylated form of b-catenin (CTNNB1) by WB. As expected, miR-372 or miR-373 induced b-catenin expression in MCF7 cells as compared with the control (Figure 3b ). Used as a positive control, LiCl was added to the culture medium and was found to markedly activate b-catenin expression (Figure 3b) .
We then analyzed the expression of cyclin-D1, c-Myc and c-Jun, which have been shown to be important downstream targets of Wnt/b-catenin (He et al., 1998; Mann et al., 1999; Shtutman et al., 1999) . As shown in Figure 3c (left panel), introduction of miR-372 or miR-373 upregulated the levels of cyclin-D1, c-Myc and c-Jun mRNA, as analyzed by quantitative RT-PCR. Expression of c-Myc and c-Jun proteins was further confirmed by WB (Figure 3c, right panel) . Therefore, these results indicate that miR-372&373 can activate Wnt/b-catenin signaling.
DKK1 is a direct target of miR-372 and miR-373
To gain insight into the mechanisms by which miR-372 and miR-373 activate Wnt/b-catenin signaling, we searched for the potential target mRNAs of miR-372 and miR-373 by using the prediction algorithm, TargetScan (release 4.1; http://www.targetscan.org). miR-372 and miR-373 share the same seed sequence (Supplementary Figure 4) and, thus, yield the same predictions. Among over 450 candidate target genes, we focused primarily on predictions related to Wnt signaling; thus, approximately 15 predicted targets were selected for further confirmation (Supplementary Table 1 ).
To test whether the predicted miRNA-binding sites in the selected candidate targets were functional, 3 0 -UTR segments harboring the WT or MT candidate motifs targeted by miR-372 and miR-373 were synthesized and subcloned downstream from the reporter gene in the psiCHECK-2 vector (Figures 4a and b and Supplementary Table 4 ). Luciferase assays were performed by co-transfection of the reporter vectors with miRNA mimics into MCF7 cells. As shown in Figure 4c , the four reporters, which harbored the WT 3 0 -UTR segments of DKK1, TGFBR2, BTG1 and LEFTY1, were significantly repressed, whereas the psiCHECK2 control vector or the corresponding MT reporters were not repressed. CD44, which was previously identified as a target of miR-373, was used as a positive control.
We next focused on DKK1, a secreted Wnt antagonist, which specifically blocks Wnt/b-catenin signaling, for further investigation. Transfection of miR-372 or miR-373 mimics suppressed DKK1 mRNA levels in HCT116 cells, as analyzed by semi-quantitative RT-PCR, where short interfering RNA for DKK1 was used as a positive control (Figure 4d ). This result was further validated by ELISAs (Figure 4e , top panel) and WB (Figure 4e , bottom panel) in both HCT116 and MCF7 cells. When miR-372 or miR-373 was blocked in SW480 or HCT15 cells using specific antisense inhibitors, DKK1 upregulation was detected either by ELISA (Figure 4f , top panel) or WB (Figure 4f , bottom panel), and the effect was more significant after miR-372&373 were simultaneously blocked (Figure 4f ).
In addition, we also analyzed the effect of miR-372&373 on the expression of TGFBR2 and BTG1, both of which have been identified previously as tumor suppressors and have been implicated in Wnt signaling (Rouault et al., 1992; Munoz et al., 2006; Avvisato et al., 2007; Falk et al., 2008) . The data showed that miR-372&373 can significantly silence TGFBR2 at the mRNA level (Supplementary Figure 5a) , whereas BTG1 was downregulated at the protein level in RKO cells (Supplementary Figure 5b) . Therefore, these results suggest that miR-372&373 may activate Wnt/b-catenin signaling by suppressing the expression of DKK1, TGFBR2, BTG1 and LEFTY1. miR-372&373 promote tumor cell proliferation and invasion by modulating DKK1 levels Studies have shown that DKK1 can inhibit the proliferation and invasion of tumor cells by antagonizing the Wnt/b-catenin-signaling pathway (Hirata et al., 2011) . We therefore explored the roles of miR-372&373 in tumorigenesis through repression of DKK1. HCT116 and MCF7 cells expressing low levels of miR-372&373 and relatively high levels of DKK1 were chosen and stable cells for overexpression of miR-372/373 or knockdown of DKK1 were generated using lentiviral constructs (Figure 5a and Supplementary Figures 6a  and b) . Quantitative RT-PCR results showed that miR-372 or miR-373 levels in HCT116 or MCF7 stable cells were significantly increased when compared with the corresponding control cells (Figure 5b ). DKK1 levels were also measured by WB and shown to be decreased in stable cells using two independent short-hairpin RNA (shRNA) constructs (Figure 5c ). Moreover, expression of b-catenin was upregulated in MCF7 stable cells for miR-372/373 overexpression or DKK1 knockdown (Supplementary Figure 6c) .
We next determined the invasive ability of the stable cells using transwell invasion assays. As shown in Figure 5d , tumor cell invasion was significantly induced in MCF7 and HCT116 stable cells overexpressing miR-372 or miR-373. As control, stable knockdown of DKK1 promoted cell invasion in both HCT116 and MCF7 cells (Figure 5d ). We further determined the cell growth of the stable cells by using monolayer colony formation assays. As shown in Figure 5e , cell proliferation was visibly stimulated in both stable HCT116 and MCF7 cells overexpressing miR-372 or miR-373, as compared with their respective control cells, and the effect of miR-372 was more significant than that of miR-373. As expected, stable knockdown of DKK1 in both HCT116 and MCF7 cells significantly stimulated cell growth (Figure 5e ). Taken together, these results indicate that miR-372&373 have important roles in modulating tumor cell proliferation and invasion, probably by repressing DKK1 expression.
Discussion
The results of this study indicated a novel Wnt/bcatenin-miR-372&373-DKK1 regulatory feedback loop, as illustrated in Figure 6 . According to this model, b-catenin/LEF1 mediates the Wnt-induced expression of the miR-371-373 cluster by directly binding to the promoter. In turn, miR-372&373 activate the Wnt/ b-catenin-signaling pathway by targeting DKK1 and other negative regulators of Wnt/b-catenin signaling. This continuous self-activated Wnt/b-catenin signaling elevates the expression of downstream transcriptional targets and, consequently, promotes tumor cell growth and invasion ( Figure 6 ). Our findings define the mutual relationship between the miR-371-373 cluster and the Wnt/b-catenin pathway in human cancer cells, which implies functional mechanisms for miR-372&373 in tumorigenesis.
The miR-371-373 cluster of miRNAs has been expected to be primarily involved in stem cell biology owing to their enrichment in human ESCs (Suh et al., 2004) . Additionally, it was found to be upregulated in human cancers, suggesting involvement in tumorigenesis. However, the regulatory mechanism of this cluster has remained largely unknown, which is necessary to understand the specific biological function of miRNAs. Our studies showed that miR-372&373 expressions were transactivated by Wnt/b-catenin signaling through b-catenin/LEF1, suggesting that their biological roles are associated with activity of the Wnt/b-catenin pathway. Likely, these miRNAs perform as downstream mediators of Wnt/b-catenin signaling to regulate genes that need to be repressed by Wnt signaling in ESCs and cancer cells. For instance, of the four targets of miR-372&373 identified here, DKK1 and TGFBR2 are known to act as both tumor suppressors and differentiation-promoting factors (Aguilera et al., 2006; Munoz et al., 2006; Falk et al., 2008; Lluis et al., 2008) .
Apart from the main pathway described above, a branch pathway is also noteworthy. Our data showed that overexpression of miR-372&373 upregulated the downstream targets of Wnt/b-catenin signaling, including c-Myc, which has a critical role in both stem cell maintenance and tumorigenesis. A recent study also showed that c-Myc directly activates the expression of the miR-371-373 cluster in liver cancer cells (Cairo et al., 2010) . Therefore, these results suggest another positive feedback loop between miR-372&373 and c-Myc, either through Wnt/b-catenin signaling or another mechanism. Both TCF/LEF1-family transcription factors and c-Myc regulate a large number of genes; therefore, the miR-371-373 cluster may indirectly impact on the global gene expression profile in human cancer cells through these feedback loops.
Researchers have found that downregulation of DKK1 in CRCs is mediated partly by epigenetic inactivation as a result of promoter hypermethylation (Aguilera et al., 2006; Sato et al., 2007) . Herein, we show that DKK1 is post-transcriptionally repressed by miR-372&373, which reveals a new mechanism by which DKK1 is downregulated in CRC cells. In addition, DKK1 was also shown to be transcriptionally activated directly by b-catenin/TCF in CRC cells (Niida et al., 2004; Gonzalez-Sancho et al., 2005) . Therefore, Wnt/b-catenin signaling appears to activate DKK1 expression and yet also activates the miR-371-373 cluster to repress DKK1 expression. A similar regulation model has been reported in the c-Myc-miR-17-5p/20a-E2F1 network in which c-Myc transactivates E2F1 expression and simultaneously represses E2F1 through activation of miR-17-5p/20a (O'Donnell et al., 2005) . Therefore, the involvement of the miR-371-373 cluster may provide precise regulation at the level of DKK1, allowing continuously activated Wnt signaling.
In CRCs containing downstream mutations of Wnt/b-catenin signaling, it has been shown that the re-expression of DKK1 cannot inhibit b-catenin/ TCF-mediated transcription (Aguilera et al., 2006) . Our results showed that lentiviral overexpression of miRNA-372/373 or knockdown of DKK1 promoted the growth and invasion of HCT116 cells in which b-catenin was mutated. Two possibilities may lead to the above result. First, DKK1 may inhibit tumor cell growth and invasion independent of Wnt/b-catenin signaling in the presence of downstream mutations, which has been proposed previously (Aguilera et al., 2006) . Second, miR-372&373 could promote tumorigenesis through targets other than DKK1. Of the targets identified, TGFBR2, which is inactivated in CRCs and suppresses tumor invasion and malignant transformation, has been reported to be a tumor suppressor (Munoz et al., 2006) . TGFBR2 ablation has been shown to lead to activation of Wnt signaling and promote the self-renewal of neuroepithelial stem cells (Falk et al., 2008) ; BTG1 has been identified as an anti-proliferation gene that is also involved in Wnt/b-catenin signaling in CRC cells (Rouault et al., 1992; Avvisato et al., 2007) .
Previous studies have identified a few miRNAs that are involved in regulating Wnt signaling. For instance, in Drosophila, miR-315 was shown to activate Wnt signaling by suppressing Axin and Notum (Silver et al., 2007) , and miR-8 family miRNAs were reported to be conserved negative regulators of Wnt signaling by repressing TCF or Wnt3a (Kennell et al., 2008) . In CRC cells, miR-135 was shown to target the APC gene directly . Coincidentally, a recent study has shown that miR-29 also forms a similar positive feedback loop with Wnt signaling during osteoblastic differentiation (Kapinas et al., 2010) , similar to miR-372&373. These findings suggest that Wnt signaling may be regulated at different steps and/or by different miRNAs depending on different biological contexts.
The self-renewal mechanisms that are crucial for maintaining stem cells are frequently deregulated in cancers and have been shown to have critical roles in tumorigenesis. Previous studies using genetic screens have indicated the contribution of the miR-371-373 cluster to tumorigenesis in testicular germ cell tumors and breast cancers (Voorhoeve et al., 2006; Huang et al., 2008) . Current findings suggest that tumors are derived from cancer stem cells, which that function as the 'root' of the tumors (Reya et al., 2001) . Cancer stem cells share many characteristics with normal stem cells, especially in the capacity of self-renewal. Given that the miR-371-373 cluster is specifically expressed in ESCs and is correlated with 'stemness' Wnt signaling, we speculate that the miR-371-373 cluster might be enriched in some types of cancer stem cells and may be revealed in further studies.
Materials and methods
Details on materials and methods are provided in the Supplementary information.
Cell lines
The cell lines used were HEK293T, MCF7 and five CRC cell lines (Caco-2, HCT15, RKO, SW480 and HCT116), which were all obtained from the Shanghai Institute of Cell Biology, Chinese Academy of Sciences.
RNA oligonucleotides miRNA mimics for miR-372&373 were obtained from GenePharma Biotech (Shanghai, China). The short interfering RNA for human DKK1 was synthesized by RIBOBIO (Guangzhou, China). The miRNA inhibitors for miR-372, miR-373 and the negative control were purchased from Ambion (Austin, TX, USA).
Antibodies
The primary antibodies used were as follows: anti-DKK1 (sc-25516, for WB), anti-BTG1 (sc-81207, for WB) and anti-cJun (sc-1694, for WB) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA); anti-b-catenin (no. 8582, for WB), anti-LEF1 (no. 2230, for WB and supershift), anti-Myc (no. 9402, for WB) and anti-a-tubulin (no. 2144, for WB) were from Cell Signaling Technology (Beverly, MA, USA); anti-LEF1 (no. 17-604, for chromatin immunoprecipitation) was from Millipore (Billerica, MA, USA); anti-b-catenin (no. 610154, for chromatin immunoprecipitation) was from BD Transduction Labs (Lexington, KY, USA).
Constructs
The plasmid pCAGGS-HA-LEF1 was a gift from Mitsuyasu Kato (Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Japan). The Topflash and Fopflash plasmids were gifts from Mengfeng Li (Department of Dermatology, Second Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China). The pcDNA3 vector (Invitrogen, San Diego, CA, USA) was used for generation of the b-catenin expression vector. The pGL3-Basic vector (Promega, Madison, WI, USA) was used for the promoter reporter constructs and the psiCHECK-2 vector (Promega) was used for the 3 0 -UTR reporter constructs. The pCDH-CMV-MSC-EF1-Puro lentivector (CD510B-1; System Biosciences, Mountain View, CA, USA) and the pGreenPuro-shRNA lentivector (SI505A-1; System Biosciences) were used for lentiviral expression of miR-372&373 and the DKK1-targeting shRNA, respectively.
Statistical analysis
All experiments were performed at least twice in triplicate. The data are presented as the mean±s.d. and Student's t-test was used to compare the control and treatment groups. Differences were considered significant when Po0.05.
